SAB Biotherapeutics- Warrants (25/07/2027) Overview
SAB Biotherapeutics- Warrants (25/07/2027) Discounted Cash Flow
DCF Analysis for SABSW.
Get informed when a big investor buys or sells
+ FollowFair Value
$0.07
Current Fair Value
$0.07
↑ 642.0% Upside
Undervalued by 642.0% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison